Page last updated: 2024-08-24

2,4-diaminoquinazoline and Lung Neoplasms

2,4-diaminoquinazoline has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, M; Guo, J; Hao, C; Pang, Y; Wang, J; Wang, K; Wu, T; Yin, W; Zhao, D; Zhu, M	1

Other Studies

1 other study(ies) available for 2,4-diaminoquinazoline and Lung Neoplasms

Article	Year
Discovery of 2-(4-Substituted-piperidin/piperazine-1-yl)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-quinazoline-2,4-diamines as PAK4 Inhibitors with Potent A549 Cell Proliferation, Migration, and Invasion Inhibition Activity. Molecules (Basel, Switzerland), 2018, Feb-14, Volume: 23, Issue:2 Topics: A549 Cells; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Neoplasm Invasiveness; p21-Activated Kinases; Quinazolines	2018

Article

Year

Discovery of 2-(4-Substituted-piperidin/piperazine-1-yl)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-quinazoline-2,4-diamines as PAK4 Inhibitors with Potent A549 Cell Proliferation, Migration, and Invasion Inhibition Activity.

Molecules (Basel, Switzerland), 2018, Feb-14, Volume: 23, Issue:2

Topics: A549 Cells; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Neoplasm Invasiveness; p21-Activated Kinases; Quinazolines

2018